Rwanda: Cervical Cancer - Rwanda Rolls Out New HPV Vaccine
Rwanda has launched a new HPV vaccine, Gardasil 9, in four districts to expand protection against cervical cancer.
Adult women have to pay up to R$ 3,000 to get vaccinated against HPV in the private network
Many adult women in Brazil face high costs to obtain the HPV vaccine due to age limits and lack of comprehensive access in the public health system.
Positive news: HPV vaccine provides long-term protection
A new Swedish study shows that the HPV vaccine reduces the risk of cervical cancer for at least 18 years, with those vaccinated before age 17 experiencing nearly an 80% lower risk than unvaccinated women.
Nonavalent Vaccine Against HPV Receives Indication for Head and Neck Tumors
Brazil's nonavalent HPV vaccine has been updated to include protection against oropharyngeal cancer and other head and neck tumors associated with the virus.
Anvisa approves new indication for HPV vaccine to prevent oropharyngeal, head, and neck cancers
Brazil's health regulatory agency Anvisa has approved a new indication for the HPV vaccine Gardasil 9 to prevent oropharyngeal, head, and neck cancers in individuals aged 9 to 45.
Jigawa reassures residents on HPV vaccine safety
The Jigawa State government has assured its residents of the safety and protective benefits of the HPV vaccine, which has been integrated into the state's immunization program for girls aged 9-14.
HPV vaccine shows lasting protection after 12 years, study indicates
A population study in Scotland shows that the HPV vaccination has long-lasting effects, with a sustained reduction in high-grade cervical lesions among over 270,000 women monitored for up to 12 years.
Rwanda: Rwanda to Introduce Vaccine Against Six Cancers
Rwanda plans to introduce Gardasil 9, a new HPV vaccine, to enhance cancer protection and aims to eliminate cervical cancer by 2027, potentially becoming the first African nation to include it in its national immunization program.
HPV: Only three times in life for early detection?
The HPV vaccine is deemed a significant medical success, capable of preventing a majority of cervical cancer cases, and Australia aims to fully eliminate the disease by 2035 due to its effective national HPV vaccination program.
Football tournament in Zimbabwe spreads awareness of cervical cancer
A football tournament in Zimbabwe highlighted cervical cancer awareness and promoted the HPV vaccine among 200 teenage girls from six African countries.